Accrol to host online investor presentation and Q&A session

Accrol Group Holdings plc (LON:ACRL), the UK’s leading independent tissue converter, has announced that it will release its Half Year Results for the six months ended 31 October 2022, alongside the outcomes of the Strategic Review, on Tuesday, 24 January 2023.

An analyst briefing will be held online at 9.00 am on that day. Equity analysts interested in joining the meeting should contact Belvedere Communications.

As part of the Group’s Results roadshow, the management will host an online investor presentation and Q&A session. This will take place on Friday, 27 January at 12.30pm. Anyone wishing to participate should register for the event with PI World at: https://bit.ly/ACRL_H123_results_webinar.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Accrol Group

More articles like this

Accrol Group

British manufacturing sees surge in sales and job creation

British manufacturing is witnessing a Brexit boost as sales rocket in the EU, Middle East and Far East, and the lifeblood of the UK economy flows once more. Major players in automotive, aerospace, construction, electrification, and

Accrol Group

Greenarc partnered with Accrol to install onsite EV chargers

Accrol Group Holdings plc (LON:ACRL) is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towel, facial tissue and biodegradable wet wipes. The UK soft tissue market is worth £1.6bn with private label products comprising

Accrol Group

UK manufacturing industry sees £48.5bn productivity boost in 2023

The UK manufacturing industry achieved productivity improvements worth £48.5bn in 2023, according to analysis of ONS data by Fourjaw Manufacturing Analytics, a technology company that measures machine productivity. This represents an 8.6% increase on 2022 levels

Accrol Group

Accrol Group returns to profit

Accrol Group, the Blackburn-based AIM-listed tissue and toilet roll maker, has achieved a return to profit, despite a dip in revenues, for its interim period of trading. In the six months to October 31, 2023, the